| J9271 | Injection, pembrolizumab, 1 mg | 6,600 | $40 | $283.8K |
| J0897 | Injection, denosumab, 1 mg | 1,860 | $20 | $35.3K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 9,660 | $1 | $19.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 160 | $100 | $16.2K |
| Q5122 | Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg | 180 | $90 | $16.2K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 200 | $80 | $16.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 70 | $70 | $4.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 40 | $90 | $3.9K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 70 | $50 | $3.5K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 290 | $10 | $3.4K |